Comparable stake leader
HIGHBRIDGE CAPITAL MANAGEMENT LLC
SEC ownership of Annovis Bio, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001477845.
Disclosed value leader
Michael B. Hoffman
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- ANVS on NYSE
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
HIGHBRIDGE CAPITAL MANAGEMENT LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
HIGHBRIDGE CAPITAL MANAGEMENT LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001477845
- Issuer location
- Malvern, PA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Annovis Bio, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HIGHBRIDGE CAPITAL MANAGE...
Disclosed value leader
Michael B. Hoffman
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 6.1%
13D/G row: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Showing 1-8 of 50 holder rows.
Quick read
HIGHBRIDGE CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 6.1%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HIGHBRIDGE CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
HIGHBRIDGE CAPITAL MANAGEMENT LLC
6.1%
Empery Asset Management, LP
5.6%
CVI Investments, Inc.
4.9%
Michael B. Hoffman
8.4%
Maria-Luisa Maccecchini
2.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
6.1%
|
$5,467,889
2,775,578 shares
|
$0 | 30 Jun 2026 |
| Empery Asset Management, LP |
13D/G
13F
Company
|
5.6%
|
$4,466,745
2,401,476 shares
|
$0 | 30 Jun 2026 |
| CVI Investments, Inc. |
13D/G
|
4.9%
|
$1,470,000
1,000,000 shares
|
$0 | 31 Mar 2025 |
| Michael B. Hoffman |
3/4/5
Director
|
8.4%
|
$7,362,310
3,811,597 shares
|
+$4,256,876 | 20 May 2026 |
| Maria-Luisa Maccecchini |
3/4/5
President & CEO, Director
|
2.7%
|
$2,484,641
1,212,020 shares
|
+$200,000 | 28 Oct 2025 |
| Claudine Bruck |
3/4/5
Director
|
0.03%
|
$1,919
13,709 shares
|
— | 10 Sep 2025 |
| Andrew Walsh |
3/4/5
Vice President, Finance
|
0%
|
$1,450
500 shares
|
— | 16 Jun 2025 |
| MARSHALL WACE, LLP |
13F
Company
|
4%
|
$3,426,750
1,842,339 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$4,456,876.
Buys
$4,456,876
Insiders: 2
Sells
$0
Insiders: 0
Net
+$4,456,876
Shares: +2,021,715
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 2,021,715
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 790,144 | 0 | $1,641,759 | $0 | +$1,641,759 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 1,231,571 | 0 | $2,815,117 | $0 | +$2,815,117 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-8 of 8 reporting-owner rows connected to Annovis Bio, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
8
Largest Forms 3/4/5 holder
Michael B. Hoffman
Net 12M change
+$4,456,876
Latest report
20 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Michael B. Hoffman | Director | $7,362,310 | +$4,256,876 | +137% | Mixed | 20 May 2026 |
| Maria-Luisa Maccecchini | President & CEO, Director | $2,484,641 | +$200,000 | +8.8% | Filing P/S | 28 Oct 2025 |
| Mark K. White | Director | $373,119 | Mixed | 20 Nov 2023 | ||
| Reid McCarthy | Director | $27,449 | Mixed | 10 Jun 2025 | ||
| Henry Hagopian III | Chief Financial Officer | $11,102 | Mixed | 20 Nov 2023 | ||
| Claudine Bruck | Director | $1,919 | Mixed | 10 Sep 2025 | ||
| Andrew Walsh | Vice President, Finance | $1,450 | Mixed | 16 Jun 2025 | ||
| Jeffrey Brian McGroarty | Chief Financial Officer | Mixed | 03 Jan 2022 |
Recent insider transactions for Annovis Bio, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Michael B. Hoffman | ANVS | Common Stock | Purchase | 2.32% | $142,779 | $1.87 | 76,344 | 3,364,883 | 20 May 2026 | Direct |
| Michael B. Hoffman | ANVS | Common Stock | Purchase | 27.7% | $1,498,980 | $2.10 | 713,800 | 3,288,539 | 02 Apr 2026 | Direct |
| Michael B. Hoffman | ANVS | Common Stock | Purchase | 1.78% | $193,794 | $4.31 | 45,000 | 2,574,739 | 08 Dec 2025 | Direct |
| Michael B. Hoffman | ANVS | Common Stock | Purchase | 1.57% | $159,886 | $4.08 | 39,200 | 2,529,739 | 24 Nov 2025 | Direct |
| Michael B. Hoffman | ANVS | Common Stock | Purchase | 1.58% | $159,886 | $4.08 | 39,200 | 2,519,739 | 24 Nov 2025 | Direct |
| Michael B. Hoffman | ANVS | Common Stock | Purchase | 0.81% | $69,900 | $3.50 | 20,000 | 2,490,539 | 21 Nov 2025 | Direct |
| Michael B. Hoffman | ANVS | Common Stock | Purchase | 0.61% | $31,650 | $2.11 | 15,000 | 2,470,539 | 14 Nov 2025 | Direct |
| Maria-Luisa Maccecchini | ANVS | Common Stock | Purchase | 8.75% | $200,000 | $2.05 | 97,561 | 1,212,020 | 28 Oct 2025 | Direct |
| Michael B. Hoffman | ANVS | Common Stock | Purchase | 65.9% | $2,000,000 | $2.05 | 975,610 | 2,455,539 | 28 Oct 2025 | Direct |
* marks a reported price that did not pass the local price check.